• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Deerfield Management

Owens & Minor taps former Thermo Fisher CCO Pesicka as prez, CEO | Personnel Moves – February 27, 2019

February 27, 2019 By Fink Densford

Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]

Filed Under: Business/Financial News, Featured Tagged With: AliveCor, Anaconda Biomed, cathworks, cirtronics, Deerfield Management, IsoRay, Magnolia Medical Technologies, mcginleyorthopedics, Owens and Minor, SurModics Inc., Thermo Fisher Scientific, Xtant Medical, Zimmer Biomet

Deerfield-backed blank-check firm’s IPO raises $250m for healthcare plays

February 22, 2018 By Sarah Faulkner

DFB Healthcare Acquisitions (NSDQ:DFBHU) said today that it closed a $250 million initial public offering. The firm’s IPO included 25,000,000 units priced at $10.00 apiece. Each unit consisted of one share of common stock and one-third of one warrant. The company said it expects its common stock to be listed on the Nasdaq under the […]

Filed Under: Initial Public Offering (IPO), Mergers & Acquisitions, Wall Street Beat Tagged With: Deerfield Management, dfbhealthcare

Court approves Nuo Therapeutics bankruptcy plan

March 30, 2016 By Brad Perriello

Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that a federal court in Delaware approved a bankruptcy plan that would either see it continue as an independent company or become 95% owned by lender Deerfield Management. Gaithersburg, Md.-based Nuo filed for Chapter 11 bankruptcy protection in January, 2 years after raising $35 million from Deerfield. Formerly known as Cytomedix, […]

Filed Under: Legal News, Wound Care Tagged With: Bankruptcy, Cytomedix Inc., Deerfield Management, Nuo Therapeutics

Nuo Therapeutics files for bankruptcy

January 27, 2016 By Brad Perriello

Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that it’s declaring Chapter 11 bankruptcy a little more than 2 years after raising $35 million. Formerly known as Cytomedix, Nuo Therapeutics makes the Aurix hematogel, which is designed to stimulate the body’s native mechanisms to heal wounds. In April 2014, the company landed a $35 million investment from Deerfield […]

Filed Under: Wall Street Beat, Wound Care Tagged With: Bankruptcy, Cytomedix Inc., Deerfield Management, Nuo Therapeutics

Diabetes: Fractyl Labs closes $57m Series C round

November 19, 2015 By Brad Perriello

Fractyl Laboratories said today that it closed a Series C round worth $57 million with a final, $17 million tranche joined by new backer Deerfield Management, as it readies its Retiva device for a Phase II trial. Waltham, Mass.-based Fractyl calls the Retiva a “duodenal mucosal resurfacing” device; it’s designed to separate the mucosa and sub-mucosa […]

Filed Under: Diabetes, Endoscopic, Funding Roundup Tagged With: Deerfield Management, Fractyl Laboratories, Venture Capital/Private Equity

Ex-Siemens Healthcare exec Sorensen gets in on Deerfield’s Imris buy

October 30, 2015 By Brad Perriello

Dr. Gregory Sorensen, the former chief of Siemens Healthcare (NYSE:SI) North America division, is taking out a minority stake in Deerfield Imaging, the former Imris business the investment company bought out of bankruptcy this year. Imris and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection last May, under a bailout plan with Deerfield Management. […]

Filed Under: Funding Roundup, Imaging Tagged With: Deerfield Management, Imris Inc., Siemens

Deerfield launches $550m healthcare fund

August 5, 2015 By Fink Densford

Deerfield Management said last week it launched a $550 million investment fund focused on the healthcare industry. The Deerfield Healthcare Innovations Fund, as it’s been titled, will seek to invest in companies looking to advance therapeutic interventions for genetic diseases, cancers and orphan diseases, as well as new disruptive technologies in the medical therapeutic delivery […]

Filed Under: Business/Financial News Tagged With: Deerfield Management

Imris files for Chapter 11 bankruptcy

May 27, 2015 By Fink Densford Leave a Comment

Imris files for bankruptcy

Imris Inc. (TSX:IM) said today that it and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection.

Filed Under: Business/Financial News, News Well Tagged With: Bankruptcy, Deerfield Management, Imris Inc.

Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015

March 6, 2015 By MassDevice

Diabetes: Tandem plans $60m offering

March 2, 2015 by Mark Hollmer

Filed Under: Diabetes, Funding Roundup, News Well Tagged With: Deerfield Management, EndoChoice, InspireMD, Orthosensor Inc., tandemdiabetes

EndoChoice raises $57m for Fuse endoscope

March 5, 2015 By Brad Perriello Leave a Comment

EndoChoice raises $57m for Fuse endoscope

EndoChoice today said it raised $57 million for its Fuse full-spectrum endoscope from a group that included prior backers and new investors.

Filed Under: Endoscopic, Funding Roundup, News Well Tagged With: Deerfield Management, EndoChoice

Direct Flow Medical raises a $32 million in funding round | Medtech funding for the week of December 1, 2014

December 5, 2014 By MassDevice Leave a Comment

TAVI: Direct Flow Medical raises $32m, names 1st CCO

December 3, 2014 by Brad Perriello

Filed Under: Funding Roundup, News Well Tagged With: Ally Bridge Group, BioStar Ventures, Blue Sky Fund, Blue Stem Capital, Conventus Orthopaedics, Covidien, Deerfield Management, Direct Flow Medical Inc., Kurma Partners, Life Sciences Partners, PDL BioPharma, Sightline Partners, Spray Fund, SV Life Sciences, VI Partners, Xeltis

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS